New TB drugs are needed for susceptible and resistant forms of tuberculosis. Our research lab provides the best tools and platforms for early stage drug development. I have been involved in high throughput screening, target identification and in vitro and in vivo activity testing for TB drugs for extended period of time. I will continue to work in this field.